GH1 and obesity due to melanocortin 4 receptor deficiency: The precise contributions of growth hormone treatment to the risk of thrombosis cannot be definitively established from these data, as growth hormone treatment is also a marker for more proactive medical management and vigilant behavioral monitoring in order to prevent the development of obesity not probed in our survey.